Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan M Boyle

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|December 17, 2016
Creatively Improving Care DeliveryBrendan M Boyle, Ivor Hill
Journal of Pediatric Gastroenterology and Nutrition|July 28, 2009
Quality of health care in the United States: implications for pediatric inflammatory bowel diseaseBrendan M Boyle, Lena Palmer, Michael D Kappelman
Inflammatory Bowel Diseases|July 3, 2009
Quality of care in inflammatory bowel disease: a review and discussionMichael D Kappelman, Lena Palmer, Brendan M Boyle, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 2, 2016
Prevalence and Impact of Functional Abdominal Pain Disorders in Children With Inflammatory Bowel Diseases (IBD-FAPD)Kevin L Watson, Sandra C Kim, Brendan M Boyle, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 10, 2016
Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center SurveyMark R Serpico, Brendan M Boyle, Kathi J Kemper, et al.
Inflammatory Bowel Diseases|April 2, 2011
Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel diseaseWallace V Crandall, Brendan M Boyle, Richard B Colletti, et al.
Clinical Pharmacokinetics|August 30, 2025
Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 17, 2023
Outcomes for Standardized Home and Hospital-Based Infusions of Infliximab for Children With Inflammatory Bowel DiseaseShivani R Gupta, Josh Bricker, Brendan M Boyle, et al.
Therapeutic Drug Monitoring|June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World DataKei Irie, Phillip Minar, Jack Reifenberg, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Gastroenterology and Nutrition|December 17, 2016
Creatively Improving Care DeliveryBrendan M Boyle, Ivor Hill
Journal of Pediatric Gastroenterology and Nutrition|July 28, 2009
Quality of health care in the United States: implications for pediatric inflammatory bowel diseaseBrendan M Boyle, Lena Palmer, Michael D Kappelman
Inflammatory Bowel Diseases|July 3, 2009
Quality of care in inflammatory bowel disease: a review and discussionMichael D Kappelman, Lena Palmer, Brendan M Boyle, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 2, 2016
Prevalence and Impact of Functional Abdominal Pain Disorders in Children With Inflammatory Bowel Diseases (IBD-FAPD)Kevin L Watson, Sandra C Kim, Brendan M Boyle, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 10, 2016
Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center SurveyMark R Serpico, Brendan M Boyle, Kathi J Kemper, et al.
Inflammatory Bowel Diseases|April 2, 2011
Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel diseaseWallace V Crandall, Brendan M Boyle, Richard B Colletti, et al.
Clinical Pharmacokinetics|August 30, 2025
Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 17, 2023
Outcomes for Standardized Home and Hospital-Based Infusions of Infliximab for Children With Inflammatory Bowel DiseaseShivani R Gupta, Josh Bricker, Brendan M Boyle, et al.
Therapeutic Drug Monitoring|June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World DataKei Irie, Phillip Minar, Jack Reifenberg, et al.
Pageof 3